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Abstract
Background: Various statistical scores have been proposed for evaluating the significance of genes
that may exhibit differential expression between two or more controlled conditions. However, in
many clinical studies to detect clinical marker genes for example, the conditions have not
necessarily been controlled well, thus condition labels are sometimes hard to obtain due to
physical, financial, and time costs. In such a situation, we can consider an unsupervised case where
labels are not available or a semi-supervised case where labels are available for a part of the whole
sample set, rather than a well-studied supervised case where all samples have their labels.
Results: We assume a latent variable model for the expression of active genes and apply the
optimal discovery procedure (ODP) proposed by Storey (2005) to the model. Our latent variable
model allows gene significance scores to be applied to unsupervised and semi-supervised cases. The
ODP framework improves detectability by sharing the estimated parameters of null and alternative
models of multiple tests over multiple genes. A theoretical consideration leads to two different
interpretations of the latent variable, i.e., it only implicitly affects the alternative model through the
model parameters, or it is explicitly included in the alternative model, so that the interpretations
correspond to two different implementations of ODP. By comparing the two implementations
through experiments with simulation data, we have found that sharing the latent variable estimation
is effective for increasing the detectability of truly active genes. We also show that the unsupervised
and semi-supervised rating of genes, which takes into account the samples without condition labels,
can improve detection of active genes in real gene discovery problems.
Conclusion:  The experimental results indicate that the ODP framework is effective for
hypotheses including latent variables and is further improved by sharing the estimations of hidden
variables over multiple tests.
Background
Selecting significantly differential genes is one of the most
important tasks in studies of gene expression analysis.
This, however, is not an easy task because gene expression
measurement studies include some difficulties, such as
high noise, a small number of measurements (samples) in
each condition, severe multiplicity of tests corresponding
to a large number of genes, and so on. Our purpose is to
improve the gene significance ranking score, by which a
larger proportion of truly active genes is referred to as sig-
nificant, while a greater proportion of truly inactive genes
is called insignificant. Here, a gene is called "active" if its
mean expression level has a relationship to the biological
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conditions of interest, and it is "inactive" if there is no
such relationship.
Most simply, the significance of genes can be evaluated
using p-values with the Bonferroni correction [1] corre-
sponding to signal-to-noise ratios. Furthermore, there
have been many studies undertaken to improve the
detectability of active genes and/or evaluate the detected
set of genes. Some of them have proposed problem-spe-
cific devices for microarray studies, and several researches
have included new general methodologies for handling
the multiplicity of statistical tests. Among them, the two
most important ideas are (a) considering family-wise
errors, and (b) sharing commonality among multiple
tests. These ideas are not limited to microarray studies, but
can also be applied to current and future bioinformatics
subjects. Family-wise errors, such as the false discovery
rate (FDR) [2], have become one of the most important
ideas in data analysis of bioinformatics subjects involving
severe multiplicity. It is becoming clearer that we cannot
discuss the significance of each objective gene based on
microarray studies; rather, we should handle a set of
hypotheses by controlling the family-wise errors.
Sharing commonality among multiple tests has become
another important issue in recent years, in order to
increase the detectability from expressed genes that are
highly correlated. The significance analysis of microarray
(SAM) [3] considers alternative statistics of the signal-to-
ratio statistics, d/(S + S0), where d is a difference of class
averages, S is a common standard deviation in each class
for each gene, and S0 is an arbitrary positive constant
appropriately given by the user. As for determining the
value of S0, which stabilizes the signal-to-noise ratio sta-
tistics when S is too small, [4] proposed a criterion that S0
is set at the 5% point of S of all genes. It was the first and
simplest way to share commonality among multiple tests.
The empirical Bayes score [5] assumes a hierarchical Bayes
model in which the priors of the parameters are common
among all genes, and the priors are hierarchically esti-
mated by using the expression of all genes. In the empiri-
cal Bayes model, the idea of sharing commonality appears
more formally, which also explains the reason why SAM
achieved similar improvement.
Very recently, Storey et al. [6,7] proposed a new frame-
work, called the optimal discovery procedure (ODP), by
extending Neyman-Pearson's lemma to multiple tests.
The ODP considers direct optimization of a family-wise
error by incorporating the idea of sharing commonality.
Namely, the above two ideas (a) and (b) are strongly inte-
grated in the ODP. Their ODP methodology is imple-
mented in their point-and-click application software,
EDGE [8].
In this study, we extend the ODP framework to general
problems in which alternative distributions are defined by
a latent variable model. Specifically, we propose a mixture
model, a typical example of a hidden variable model,
which assumes a stochastic noise process in each condi-
tion and includes a latent (hidden) variable indicating a
class label of the condition to which the sample belongs.
Since the label is regarded as a hidden variable, it is not
necessarily provided. This model is then lent to two new
significance scores of genes; an unsupervised significance
score that assumes the class labels are not provided, and a
semi-supervised significance score that can deal with sam-
ples either with or without class labels. We found that
there are generally two theoretically natural but different
ways to deal with the hidden variables in the ODP man-
ner; namely, the estimated values of hidden variables are
shared among multiple tests explicitly or implicitly
through the model parameters. We compare them
through a simulation experiment and show that explicit
sharing of the commonality in the hidden variable
improves the detectability of active genes. Using artificial
and real data sets, we also show that the unsupervised and
semi-supervised score of gene significance can improve
the stability of active gene ranking against a small number
of labeled samples by incorporating the unlabeled sam-
ples.
Neyman-Pearson's lemma and the supervised gene 
significance score
Our objective is to accurately determine whether a gene i
is active or inactive, according to the expression data xi =
(xi1, xi2, ..., xiM) and label information Y = (y1, ...,yM), yj ∈
{1, 2}, j = 1, ..., M, over M measurements (samples).
Following the conventional framework of statistical test-
ing, let the null hypothesis that the gene is actually inac-
tive be denoted as H0 , and the alternative hypothesis that
the gene is actually active be denoted as H1. Our question
is what kind of significance score S is best for discriminat-
ing active genes from inactive ones based on a limited
number of measurements such as in conventional micro-
array experiments. The null and the alternative models
can be represented as null and alternative probability den-
sity functions (PDFs), f  (Xi) = p(Xi|H0) and g(Xi) =
p(Xi|H1), respectively; namely, they are simple hypotheses
with no variable parameter. Then, the following likeli-
hood ratio score is known as the most powerful score of
significance:
which was stated and proven as Neyman-Pearson's
lemma [9].
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Many useful statistical tests, however, assume non-simple
hypothetical models so that the null and alternative PDFs
include variable parameters to be estimated statistically.
For example, in a typical approach for supervised differen-
tial gene discovery [10], the null and the alternative mod-
els are defined as
where  φi = { } and θi = {μi(1),  μi(2), } are the
parameters of the null and alternative models, respec-
tively. N(x|μ, σ2) denotes a normal density function with
a mean μ and a variance σ2. μi(1) and μi(2) are the centers
of normal distributions for yj = 1 (class 1) and yj = 2 (class
2), respectively.   and   are intra-class variances
under the null and alternative hypotheses, respectively.
For simplicity in our discussion, we assume that the
expression data are normalized such that (1/M)
 holds. In this case, the log likelihood ratio
can define a significance score of a single gene i:
where the maximum likelihood estimates (MLEs) of the
parameters are given as:  , (k = 1,
2), ,  and  .
Here, I(A) is an index function that outputs 1 when con-
dition A is satisfied; otherwise, the output is 0. By assign-
ing the MLE to the significance score, the following
estimated log likelihood ratio function is available as a
score:
Accordingly, the supervised score LR-S(Xi) is specified by
the signal-to-noise (S/N) ratio  . The estimated
likelihood ratio score for parametric hypothetical models
is not necessarily the most powerful, as stated in the Ney-
man-Pearson's lemma, because of the variance in the
parameter estimation. Although it becomes the most
powerful asymptotically as the number of samples grows
to infinity, there may be a better score if the number of
samples is finite.
Models and algorithms
Unsupervised and semi-supervised likelihood models
For an active gene, gene expression is assumed to relate to
the condition of each sample; in other words, it is "on" in
samples in certain conditions and "off" in others. Let a
hidden variable
Zi = (zi1, ..., ziM), zij ∈ {1, 2}, j = 1, ..., M denote whether
the gene i is "on," zij = 1, or "off," zij = 2, in a sample j. In
particular, we consider the binary categorization of condi-
tions but allow uncertainty. Namely, the supervised label
y is either 1 (class 1), 2 (class 2), or 0 (label unknown). An
unsupervised case is defined as y = 0 for all j, and a semi-
supervised case is defined as y = 0 for only some j.
Unsupervised significance score
For an active gene i, we assume a mixture of normal distri-
butions for its expression xij in a sample j:
where ν(k) is the prior probability that the hidden varia-
ble zij takes k ∈ {1, 2}. We assume ν(k) is independent of
i or j. Under the alternative hypothesis H1, the likelihood
function of the parameter θi = (ν(1),  ν(2),  μ(1),  μ(2),
), given the expression vector Xi ≡ {xi1,..., xiM} of gene
i, is given by
The null hypothesis is the same as given in the supervised
case, i.e., a normal distribution:
The log-likelihood ratio score is then defined as
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where  f (Xi; φi) and  g(Xi; θi)
are the MLEs for the two hypotheses.
When we have an MLE   for the alternative hypothesis,
the posterior of the hidden variable zij, given a datum xij,
is obtained as
Let   = (  (k); j = 1, ..., M, k = 1, 2) be the matrix of the
estimated posterior, where 0 ≤   ( k) ≤ 1 and ∑k  (k) =
1 hold. The matrix   will be used later when we consider
multiple testing.
Semi-supervised significance score
In the semi-supervised case, an active gene can be mod-
eled by modifying the prior of the hidden variable so that
the prior incorporates the label's inobservability:
P(zij = k|yj, θi) = I(yj = k) + I(yj = 0)ν(k), k = 1, 2.   (11)
This prior states that the hidden label is the same as the
observed label when it is observed, but is predominantly
predicted by the prior knowledge ν(k) when it is unob-
served; the point is, we regard the observation as prior
information. Accordingly, a semi-supervised case is dealt
with by simply employing the same prior as in the unsu-
pervised case, Eq. (11), but the first term vanishes because
I(yj = 0) for every j. Namely, the log-likelihood ratio score
in a semi-supervised case, LR-SS(Xi), is defined as in the
unsupervised case except that the prior P(zij = k|θi)in Eq.
(6) is replaced by P(zij = k|yj, θi) in Eq. (11).
Optimal discovery procedure
ODP lemma and its application
According to Neyman-Pearson's lemma, a statistic is
defined as being most powerful when its detection proba-
bility β is the largest with a fixed significance rate α, and
the likelihood ratio is proven to be the most powerful
when the null and alternative hypotheses are both simple.
Storey et al. (2005) [6,7] extended Neyman-Pearson's
framework to multiple testing and proposed a new gen-
eral framework, ODP. They defined that a statistic is opti-
mal if it maximizes the expected true positive (ETP) rate
when fixing the expected false positive (EFP) rate. They
also showed that an ODP function is available as in the
following ODP lemma, which is not the same as the like-
lihood ratio.
ODP lemma
Let SODP be a common statistic, called an ODP function, for all
genes:
where X is a gene expression vector (its dimensionality corre-
sponds to the number of samples). Then, the criterion that the
gene is significant when SODP (Xi) > λ for any threshold λ > 0
is an ODP. In Eq. (12), G0 and G1 are index sets of inactive
and active genes, respectively.
This lemma defines an ideal ODP but not a practical one,
because it needs information not available in actual situa-
tions of multiple testing. The true values of parameters θ
and φ  are not available and are instead substituted by
MLEs estimated from the observed data. Furthermore, G0
and G1 are not available in a real situation either, because
there is no need to calculate significance scores if we know
G0 and G1. For practical use, therefore, Storey et al. pro-
posed an approximate ODP criterion:
where  g  (Xi|θi) and  f(Xi|φi)
are the MLEs. Note here that the summation in the numer-
ator is taken over all genes, and that the summation in the
denominator is taken for a roughly estimated set of inac-
tive genes,  . As an example, they proposed   =
{j|g(Xj|) / f(Xj|)  < ε}, where ε is an arbitrary positive
threshold; that is,   is a set of genes that are not signifi-
cant by the standard gene-wise likelihood ratio test.
By applying the typical ODP estimation to supervised dif-
ferential gene discovery problems for artificial and real
data sets, they showed that ODP is better at detecting
active genes than the existing methods. This means a
larger number of genes were obtained at each fixed false
discovery rate (FDR), where the FDR was estimated by a
permutation test.
The key of the ODP in contrast to the individual likeli-
hood ratio is that ODP shares among all genes common
information about the distributions represented as null
and alternative models, so that the common information
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is used when evaluating a single gene. They actually dem-
onstrated that, when the hypothetical models have some
global characters shared by the genes, such as an asym-
metric or cluster structure or both, ODP can incorporate
them to improve the performance of gene discovery, i.e.,
to increase the ETP for a fixed EFP.
ODP to latent variable models
For parametric hypothetical models, the distribution of
hypotheses is attributed to the distribution of model
parameters. When there are hidden variables, as in our
model's case, other definitions of the hypothesis are pos-
sible: (a) unknown values of the hidden variables are mar-
ginalized out in the hypotheses, or (b) the hidden
variables are explicitly included, as are the model param-
eters in the hypothetical models. In case (b), the distribu-
tion of hypotheses is attributed to the distributions of
both model parameters and hidden variables. These two
definitions of the hypothesis distribution lead to different
results. We formalize these two cases in this section and
compare them in the next one.
In the likelihood ratio score, we evaluate the ratio of the
two likelihood functions, g(·| ) and f (·| ), for each
gene i', where we estimate the parameters of the null and
alternative models,   and  , respectively, as MLEs, and
the hidden variable in the alternative model, as its poste-
rior,  . In the ODP, only a single significance function,
(13), is constructed by using a set of hypotheses, each of
which corresponds to a single gene; hence, the likelihood
functions, g (·| ) and f (·| ), for gene i' are shared by
all genes. Namely, in the ODP, we evaluate g(Xi|)  a n d
f(Xi|)  f o r  i ≠ i', and the key difference between cases (a)
and (b) is in the way this process is carried out.
In case (a), i.e., when only the model parameters are
shared by all genes, the likelihood function becomes
In case (b), i.e., when the estimated posterior of the hid-
den variable,  , is also shared, the likelihood function
becomes
As we pointed out at the beginning of this section, the dif-
ference between the two cases above comes from the dif-
ference in the interpretation of what the model is and
what the hypothesis is. In fact, if one assumes that the pos-
terior of the hidden variable   is a part of the unknown
parameter θi', then the second case is a special case of the
original ODP. Namely, in case (a), the alternative hypoth-
esis of a single gene is dependent on the expression distri-
butions of the two groups of samples, while the
alternative hypothesis in case (b) is dependent not only
on the expression distributions but also on the class labels
of the samples. When we ignore the multiplicity of statis-
tical testing, these two cases are identical because the hid-
den variable is uniquely determined, even
probabilistically, from the estimated parameter of the sin-
gle-gene model.
The model in case (b) may have a biological meaning. The
hidden variable vector Zi can be regarded as an on/off
(binary) pattern vector of gene i over the samples. Since
some biology, such as gene regulatory factors, may be rep-
resented as characteristic distributions of binary pattern
vectors, the ODP framework will be able to apply such
characteristics by sharing the underlying biological infor-
mation in multiple tests.
Results
Strictly speaking, a gene is called active if the true mean
expression levels are different in different conditions
regardless of whether the difference is large or small. How-
ever, in real situations it is impossible in principle to
know whether a gene is truly active or inactive because its
definition must be based on a finite (and often small)
number of samples. Note also that it is difficult to confirm
ever from any biological experiments whether any gene is
truly active or inactive in the strictest sense – it is only a
matter of the degree of significance.
In order to compare gene selection criteria, one solid way
to consider an artificial situation where expression levels
of truly active and truly inactive genes are given by proba-
bilistic sampling from known probability densities on
gene expression levels. On the other hand, we should also
conduct experiments on real data sets because true distri-
butions of gene expression levels of active and inactive
genes are not necessarily the same as artificial distribu-
ˆ θi ˆ φi
ˆ θi ˆ φi
ˆ Zi′
ˆ θi ˆ φi
ˆ θi
ˆ φi
ˆ(| ˆ )( | ˆ )
ˆ() ( |ˆ () ,ˆ )
gX px
kNx k
ii i ji
j
M
ij i i
k
θθ
νμ σ
′′
=
′′
=
=
=
∏
1
1
2
1
2 2
1
14
∑ ∏
=
()
j
M
.
ˆ Zi′
ˆ(| ˆ , ˆ )( | ˆ ˆ )
ˆ () ( |ˆ
gX Z px z
zk N x
iii i ji j i
j
M
ij i j i
θ, θ
μ
′′ ′′
=
′′
=
=
∏
1
( () ,ˆ ). k i
k j
M
σ1
2
1
2
1
15
′
= =
∑ ∏
()
ˆ Zi′BMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
Page 6 of 13
(page number not for citation purposes)
tions. Since we can expect that when the amount of infor-
mation corresponding to the number of samples
increases, gene rankings based on any statistical signifi-
cance scores become more stable, we prepared a provi-
sional target based on a sufficiently large number of
labeled data sets. Based on the provisional target, we com-
pared some gene significance scores with each other by
evaluating stabilities against loss of information corre-
sponding to loss of the number of labeled samples in real-
istic situations.
Unsupervised differential gene discovery in artificial data
First of all, we compare various unsupervised scores
devised for the detection of significant genes in an artifi-
cial setting.
Figure 1A shows the structure of an artificial data set con-
sisting of the expression of 6,400 genes for 16 samples.
These 6,400 genes are made up of four groups, each of
which includes 1,600 genes: groups (1) and (2) are inac-
tive, and groups (3) and (4) are active, where the noise
variance in group (1) is larger than in (2), and active genes
are "on" in different samples of groups (3) and (4). The
artificial gene expression levels are made from random
samplings of normal distributions with certain means and
variances, because logarithms of the gene expression
ratios are known to be approximately normally distrib-
uted [10]. We compared the three scores listed below:
￿ LR-U, a gene-wise likelihood ratio, which is independ-
ent of the other genes;
￿ ODPp-U, an ODP based on the case (a) model, which
shares the estimation of model parameters; and,
￿ ODP-U, an ODP based on the case (b) model, which
shares the estimation of both model parameters and hid-
den variables.
Figures 1B and 1C show the results. In Fig. 1C, we can see
ODP-U outperformed the others, i.e., it achieved the best
sensitivity for each specificity, while LR-U was the worst.
In Fig. 1B, we can see that the LR-U score is insensitive to
the difference between the groups (1) and (2), or between
(3) and (4). On the other hand, the score ODPp-U
behaves differently between (1) and (2), i.e., the genes in
group (1), which exhibit expressions with larger variance,
tend to be evaluated as more significant because a larger
variance likely causes a high chance of detecting active
(possibly false) genes. However, the ODPp-U was insensi-
tive to the difference between (3) and (4), which have the
same expression distribution. The principal characteristic
of the ODP-U score is that it extracted a larger number of
active genes in group (4), suggesting an advantage of
ODP-U. Since the 1,600 genes in group (4) have an iden-
tical pattern of true hidden variables, the commonality
boosted the significance scores of genes in the same
group. In group (3), the number of genes sharing the true
hidden variables was 200, which led to weaker boosting
of the significance scores than in group (4).
These results show that sharing the estimation of both the
parameter and the hidden variable is effective in gene dis-
covery when they have some structures that can be
imprinted by making multiple tests cooperative. Also, we
found that the more genes there are in the same group, the
more effective is the sharing of the hidden variable estima-
tion.
Semi-supervised differential gene discovery on artificial 
data
Next, we consider the semi-supervised case. In the 16 sam-
ples, we assumed eight samples (index: 1,2,...,8) to have
the true class label 1 and the other eight samples (index:
9,10,...,16) to have the class label 2. For each class, five
samples were correctly labeled but the other sample labels
were unknown. Note that the group (3) genes were
assumed to be inactive in this case, because the sample
labels represented by these genes (Fig. 1A) are not corre-
lated with the labels of interest here. We compared the
four scores listed below:
￿ SAM, SAM statistics;
￿ LR-S, likelihood ratio score;
￿ ODP-S, an ODP using only the samples with labels; and,
￿ ODP-SS, an ODP using all samples with the labels being
known or unknown.
The three supervised scores, SAM, LR-S, and ODP-S, used
the ten samples with labels to calculate their gene scores,
while ODP-SS used, in addition, the remaining six unla-
belled samples to estimate the unknowns in the hypothe-
sis models.
The ROC curves in Fig. 2A illustrate that ODP-SS achieved
the best specificity for each sensitivity. Although SAM
showed a better detectability than the conventional likeli-
hood ratio, ODP-S exhibited far better specificity for each
sensitivity. Figure 2B shows the distributions of ODP-SS
for the four gene groups, (1), (2), (3), and (4). The active
genes in group (4) were evaluated as clearly more signifi-
cant than in the other groups by our ODP-SS score. How-
ever, the score distribution of gene group (3) is
interesting. Although the distribution of expressions of
inactive group (3) is identical to that of active group (4),
the score distribution of group (3) is quite different fromBMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
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Unsupervised extraction of significant genes Figure 1
Unsupervised extraction of significant genes. (A) An artificial data set and its generative models. The artificial gene 
expression data set consists of 6,400 genes for 16 samples. The 6,400 genes are made up of 3,200 inactive ((1) and (2)) and 
3,200 active ((3) and (4)) genes. Expressions of the inactive genes are generated from a normal distribution with mean 0 and 
variance 1.22 or 0.82 for gene group (1) or (2), respectively. Since the genes are generated from a single distribution regardless 
of the sample index, they are in fact inactive. Expressions of active genes are generated from a normal distribution with mean 
1.0 or -1.0 for highly or lowly expressed genes in each sample, respectively, and a common variance 1.0. The expression pat-
tern for each gene is different between groups (3) and (4): in group (3), there are eight subgroups of 200 genes and each sub-
group has a high/low pattern different from the other subgroups. In group (4), 1,600 genes have the same high/low pattern. In 
(4), all the genes are assumed to reflect a common biology leading to similar expressions over all samples, and in (3) there are 
eight gene clusters, each of which reflects its own biology. (B) Histogram of three unsupervised significance scores: LR-U, 
ODPp-U, and ODP-U, which are separately described for the four gene groups. Horizontal axes are shown in log-scale. A ver-
tical line denotes the mean of the distribution. (C) ROC (receiver operating characteristic) curves of active gene detection gen-
erated by changing the threshold for each score; the horizontal and vertical axes denote specificity, (true negative/(true 
negative + false positive)), and sensitivity, (true positive/(true positive + false negative)), respectively.BMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
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(4) but similar to those of (1) and (2) instead, which are
also inactive with respect to the biology represented as the
true label pattern. Even when the labeling includes uncer-
tainty, the information of the labels affected the signifi-
cance of the genes, which is stronger than the information
of the expression distribution.
Application to real data
In this section, we demonstrate the stability of the pro-
posed semi-supervised and unsupervised scores based on
two real data sets.
Prostate data set
The Prostate data set [11] consists of 52 prostate tumor
samples and 50 normal samples, each of which was meas-
ured by origonucleotide microarrays (U95Av2 arrays,
Affymetrix). Significant changes of expression levels were
obtained at 10,509 probes out of approximately 12,600
genes and ESTs. In the original paper, signal-to-noise ratio
is used to detect significant genes, and 317 genes with
higher expression in the tumor samples and 139 genes
with higher expression in normal prostate samples, i.e.,
456 genes in total, were called significant based on a crite-
rion, p < 0.001.
To overview of the data set, we consult the application
software EDGE [8], which is based on an original imple-
mentation of ODP-S score and includes a procedure to
estimate FDR. Figure 3A show the resultant histograms of
p-values for the Prostate data set. From the p-value distri-
bution, FDR is estimated for any threshold of the signifi-
cance score, which indicates the proportion of the genes
that are estimated as differential. When the top 1%, 10%,
and 50% genes classified as significant, the estimated
FDRs were 2.8 × 10-6, 0.00043, and 0.0105, respectively.
For reference, the number of significant genes for the same
threshold p < 0.001 obtained by EDGE, was 1293; this
number is larger than the total number based on signal-
to-noise ratio above, indicating higher detectability by the
ODP.
Colon data set
The Colon cancer data set [12] consists of 40 colorectal
tumor samples and 22 normal samples, each of which was
measured by origonucleotide microarrays (Hum6000
arrays, Affymetrix). They selected 2,000 genes, from about
3,200 human cDNAs and 3,400 ESTs, which exhibited the
greatest minimal intensity across the 62 samples. By
applying EDGE to this data set (Figure 3B), when the top
1%, 10%, and 50% genes are classified as significant, the
estimated FDRs were 0.00025, 0.0095, and 0.22. That
indicates less proportion of genes in the Colon data set are
significant than in the Prostate data set.
Experiment settings and results
We randomly masked sample label information except for
4, 6, 8, N/4, N/3, or N/2 samples, where the numbers of
positive and negative labels in the non-masked samples
are set to be same. Supervised scores SAM and ODP-S, and
semi-supervised score ODP-SS are calculated based on the
gene expressions and the non-masked labels, and corre-
sponding significance rankings of all genes are also calcu-
Semi-supervised extraction of significant genes from the  same artificial data shown in Fig. 1(A) Figure 2
Semi-supervised extraction of significant genes from 
the same artificial data shown in Fig. 1(A). The true 
labels of the 16 samples are 1 for the earlier eight samples 
and 2 for the rest, but three samples of both classes are 
assumed to be unknown (labeled as * in the figure title). This 
experiment evaluates how many genes in the truly active 
1,600 genes of group (4) can be detected by four significance 
scores: LR-S, SAM, ODP-S, and ODP-SS. Note that the genes 
in group (3) are regarded as inactive in this experiment 
because the high/low patterns are different from the true 
label pattern. Therefore, there are 4,800 inactive genes 
(groups (1), (2), and (3)) and 1,600 active ones (group (4)). 
(A) ROC curves of the four scores. The number for each 
score denotes the AUC (area under the curve) values. (B) 
Distributions of the ODP-SS scores for the four gene groups, 
(1), (2), (3), and (4). Horizontal axis is shown in log-scale.BMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
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lated. The relevance of these rankings is evaluated by
concordance to the most reliable ranking based on the
ODP-S score calculated by using the complete data with-
out masked labels; i.e., this ranking is used as a provision-
ally true ranking.
Spearman's rank correlation, a well known criterion for
evaluating the correlation between two different rankings,
is used for evaluating concordance between two rankings:
where Ai and   are the rankings of gene i according to
two criteria A and A', respectively. However, when we are
interested in knowing whether each gene is top-ranked or
not, and a detailed ranking of lower-ranked genes is not
very important, the Spearman's rank correlation, RS,
seems inappropriate because it is equally sensitive to dif-
ferences of rankings both in top-ranked and bottom-
ranked genes. We also considered another criteria. Area
under the ROC curve, to detect the top α% genes, in short,
AUCα is a criterion quite similar to the one we used in the
previous simulation study except that true active genes are
provisionally defined as the top α% genes of the provi-
sional target ranking, ODP-S. We used α = 1 and 10 in the
following experiment. The AUCα criterion can be used to
evaluate the detectability of provisional genes from the
objective ranking without determining the threshold of
the objective ranking to define the significance or insignif-
icance of genes. These two criteria are -1 ≤ RS ≤ 1 and 0 ≤
AUCα ≤ 1, and the chance levels for random rankings are
0 for the Spearman's criterion RS and 0.5 for the AUCα .
Figure 4 shows the results of the three comparisons based
on Spearman's rank correlation ((A) and (D)), AUC10%
((B) and (E)), AUC1% ((C) and (F)), for the Prostate data
set ((A), (B), and (C)), and for the Colon data set ((D),
(E), and (F)). In each of the panels (A)-(F), the horizontal
axis denotes the conditions, i.e., the number K  of
observed labels, where N is the total number of labeled
samples in the original data sets. Blue, green, and red dots
denote the compared scores, SAM, ODP-S, and ODP-SS,
respectively, calculated based on 30 trials of random selec-
tion of the masked labels for each condition. Means of the
30 trials for each condition are plotted with real lines in
the same color as the corresponding dots. Note that the
ODP-SS (denoted by red) at K = 0 is equivalent to the
unsupervised score ODP-U, and the ODP-SS at K = N is
equivalent to the supervised score ODP-S.
In the case of K = N, we confirmed that SAM and ODP-S
showed very similar rankings from the results in which all
of the three concordance criteria become nearly 1.0,
which indicate the stability of the provisional target, i.e.,
ODP-S ranking on K = N. We performed a further experi-
ment based on another provisional target, ranking of SAM
on K = N, and we obtained almost identical results (not
shown). For all rankings, all sample data sets, and all con-
cordance criteria, we confirmed that concordance
between any ranking to the provisional target tends to be
lower, and their variances tend to be larger, for smaller
numbers of labeled samples K.
Based on the Spearman's rank correlation to the provi-
sional answer for the Prostate data set, Fig. 4A, the pro-
posed semi-supervised ranking of genes, ODP-SS, showed
better concordance than the rankings of SAM and of ODP-
S for the cases with relatively small numbers of labeled
samples K. ODP-SS at K = 0, i.e. the unsupervised ranking
ODP-U, shows also moderately better concordance,
which exceeds that of SAM and ODP-S at K ≤ 8. These
results indicate that unlabeled samples can improve the
gene selection accuracy.
For the Colon data set, on the other hand, the Spearman's
rank correlation to the provisional answer (D) did not dis-
play any prominent difference between any two rankings
in the three objectives. Other criteria, AUC10% (E) and
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P-value histograms for the two real data sets Figure 3
P-value histograms for the two real data sets. P-value 
histograms of all genes for the Prostate data set (A) and the 
Colon data set (B). Horizontal axes denote P-values calcu-
lated by EDGE [8] which is an application software based on 
the ODP-S score discussed in the current paper.BMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
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Demonstration of semi-supervised score based on the real data sets Figure 4
Demonstration of semi-supervised score based on the real data sets. Four comparisons based on Spearman's rank 
correlation ((A) and (D)), AUC 10% ((B) and (E)), and AUC1% ((C) and (F)). for the Prostate data set ((A), (B), and (C)), and 
for the Colon data set ((D), (E), and (F)). In each of the panels (A)-(F), the horizontal axis denotes the conditions, i.e., the num-
bers K of observed labels, where N is the total number of labeled samples in the original data sets. Blue, green, and red dots 
denote the compared scores, SAM, ODP-S, and ODP-SS, respectively, calculated based on 30 trials of random selection of the 
masked labels for each condition. Means of the 30 trials for each condition are plotted with lines in the colors of the corre-
sponding dots.BMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
Page 11 of 13
(page number not for citation purposes)
AUC1% (F), however, showed prominent the superiority
of ODP-SS or ODP-U in cases when the number of
labeled samples was smaller K ≤ 8, which also indicates
possible improvement. It is interesting that ODP-SS,
based on a limited number of labeled samples, performed
far worse than ODP-U which did not use any labels for the
Colon data set. Furthermore, ODP-SS performed slightly
below the supervised scores of ODP-S and SAM for the
cases where the number of labeled data K were large for
the Prostate data set. One possible reason for this is labe-
ling error or its equivalent process. Labeling error is the
result of confusion between tumor and normal samples
that could not be trusted for inclusion in the original data
set. However, in its equivalent process there may exist,
some true active genes that more closely correspond to
another binary label of samples than the tumor/non-
tumor label. If the other label correlates closely enough
with the original label, the detected set of significant genes
will be almost the same between the scores based on the
two labels. The degree of significance, however, may
change depending on the selection of supervised or semi-
supervised scores, because supervised scores rely heavily
on the sample labels whereas semi-supervised scores rely
greatly on the shapes of distributions. These possible
effects of labeling errors should be considered further in
future works.
We did not find any prominent difference between the
supervised scores of SAM and ODP-S in these cases. That
is, the two scores were almost equivalent with respect to
the ability to detect a small number of top-ranked genes,
and a small difference existed only in rankings among the
top genes.
Discussion
Discriminant analysis is another important aspect, differ-
ent from differential gene detection, for selecting a small
subset of important genes from microarray experiments.
In discriminant analysis, a set of genes is determined to
optimize the accuracy of sample prediction based on a
certain method, such as using a support vector machine
(SVM). As a typical example, the recursive feature elimina-
tion (RFE) method is considered to be one relevant way of
optimizing the performance of SVMs [13]. In this case,
however, the selected set of genes is not very meaningful
biologically, because each one of the selected genes is not
necessarily more important than the others, and no partic-
ular one of the remaining genes has enough reason to be
ignored from a biological perspective. Differential gene
detection is sometimes used for discriminant analysis. For
example, the weighted vote method [14], and shrunken
centroid [15] use a certain number of top-ranked genes
ordered by classical criteria to evaluate differential genes,
where only the number of top-ranked genes are deter-
mined based on sample discrimination accuracy with
cross-validation or other devices. In short, although gene
ranking based on statistical significance is useful for dis-
criminant analysis, gene sets determined for improving
discriminant analysis cannot be used to represent the sig-
nificance of any single gene.
Semi-supervised analysis denotes the cases where unla-
beled samples are used along with labeled samples. There
have been many studies conducted on semi-supervised
learning to improve discriminant accuracy by incorporat-
ing it with unlabeled samples from the general viewpoint
of machine learning, ex. [16]. In addition, there is an
application of semi-supervised learning to protein classi-
fication [17]. However, to the best of our knowledge there
are no studies on semi-supervised detection of differential
genes. There is, however, one on unsupervised gene selec-
tion based on entropy [18].
Bair and Tibshirani (2004) [19] proposed interesting pro-
cedures for sample discrimination by first selecting some
significant genes using a certain supervised score, fol-
lowed by a process that uses a certain unsupervised analy-
sis, such as PCA or K-means clustering. They called their
procedures "semi-supervised methods." Our study on
semi-supervised detection of differential genes has no
direct relationship to their "semi-supervised methods"
because, from the viewpoint of machine learning termi-
nology we adopt, their methods are actually "supervised"
discriminant analysis rather than "semi-supervised." Their
"supervised" methods, however, seem very good ways to
avoid over-fitting to sample vectors when the number of
samples is small, and the vectors are noisy and high-
dimensional. Moreover, they will be further improved by
using better differential scores of genes, such as by using
our "semi-supervised" gene ranking incorporating many
additional unlabeled samples, if available.
There had been many problem-specific devices proposed
for modeling various effects of noise in microarray stud-
ies. Parametric models on noise in microarrays [20,21] or
non-parametric treatment [22] improved the null and
alternative distribution of microarray measurement. Baye-
sian hierarchical modeling can include various factors in
a united manner, and there have also been some improve-
ments in recent years, [23-25]. In the current study, we
used the simplest normal mixture model for semi-super-
vised gene discovery, although the various devices men-
tioned above may further improve the accuracy in future
works. In general, a differential gene-detection problem
consists of two steps: ranking the genes according to the
significance score derived for a given set of null and alter-
native hypotheses, and deciding the threshold for deter-
mining whether a gene is significant/insignificant based
on the estimated false discovery rate (FDR) or other crite-
ria. In this paper, we showed that the gene-ranking stepBMC Bioinformatics 2006, 7:414 http://www.biomedcentral.com/1471-2105/7/414
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can be improved by combining a latent variable model
and the ODP framework, particularly in unsupervised and
semi-supervised cases. We also showed that sharing the
estimation of hidden variables is effective in the ODP
framework for dealing with multiple testing.
Although Storey et al. [6,7] estimated an FDR based on
ODP-S by using permutation of the class labels, we did
not consider FDR in this paper. In an unsupervised case,
class labels are missing and their permutation is impossi-
ble to perform, and in a semi-supervised case it is also dif-
ficult to consistently perform the permutation of labels.
ODP requires a computational cost of O(N2), where N is
the number of genes, and FDR estimation employing per-
mutation would require the cost of a certain number of
times (not small), as many as that for the ODP.
The need for better ranking never declines even when FDR
estimation is not available. Gene ranking is typically
required as an essential process for selecting candidate
genes to reduce the cost of experiments in order to exam-
ine whether the top-ranked genes can be targets for medi-
cal treatment or can be as possible diagnosis markers.
Therefore, ranking performance vital regardless of the
existence of a way to determine the threshold by consider-
ing an FDR.
In this study, we demonstrated an improvement in gene-
ranking estimation in semi-supervised and unsupervised
cases for artificial and real data sets. We have shown that
the stability of gene-ranking for small number of labeled
samples can be drastically enhanced by incorporating
unlabeled samples in a semi-supervised manner. On the
other hand, for a sufficient number of labeled samples,
the difference between the supervised and semi-super-
vised rankings was not prominent. Consequently, the
optimal situation where the semi-supervised ranking of
genes will exhibit prominent performance is in cases
where the number of labeled samples is small whereas the
number of unlabeled samples is large. There will be such
a typical semi-supervised situation because sometimes it
is not very difficult to measure a lot of samples by means
of cheap microarrays, while to apply a label to each sam-
ple still incurs a large amount of time, money, and other
miscellaneous costs. For example, to apply dead/alive in
clinical applications may take several years to follow up.
Although the unsupervised score also exhibited fairly
good concordance to the provisional supervised ranking
corresponding to the difference between normal and
tumor, it will not necessarily behave similarly in other sit-
uations corresponding, for example, to the difference
between different types of tumors because the unsuper-
vised score may pick up any genes that actively correspond
to any differences. This characteristic of the unsupervised
score was shown in the experiment using artificial data,
where many genes in group (3), whose distributions have
multimodality, were picked up even though they had no
relationship to the main objective normal/tumor label.
Consequently, the unsupervised score can effectively be
used as an alternative way of filtering insignificant genes
out in the pre-processing of gene expression analyses.
Applying various latent variable models such as a mixture
of the t-distribution model, Cox's proportional hazards
model, and so on, may lead to useful gene ranking within
our framework, and such an application will be our future
work.
Conclusion
In general, sharing commonarities of hypothetical models
over multiple tests has been thought as an important key
of multiple testing problem. And, the ODP framework
[6,7] had proposed a theoretically optimal way of sharing
hypothetical models by sharing likelihood function based
on maximum likelihood (ML) parameters.
We, in this paper, found that application of the ODP to
latent variable models generally has two different possi-
bilities, namely, the estimated hidden variables for other
genes are shared or not. As an application of the ODP to
latent variable models, we proposed new unsupervised
and semi-supervised significance scores of genes based on
a simple latent variable model, normal mixture model.
The simulation results indicated that the ODP framework
is effective for hypotheses including latent variables and is
further improved by sharing the estimations of hidden
variables over multiple tests. The real data experiments
showed that incorporation of the unlabeled samples by
using the proposed unsupervised or semi-supervised score
can improve the detectability of active genes.
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